image_name stringlengths 68 68 | type stringclasses 2
values | gt_table stringlengths 116 12.6k |
|---|---|---|
26cc285aac7120c2adaf25b6c38baaac6cf226850b578a6a477b3f631ac18c02.png | complex | <table><tr><td rowspan="3">Variables</td><td>Overall</td><td rowspan="3"><i>p</i>-Value</td><td>Women</td><td rowspan="3"><i>p</i>-Value</td><td>Men</td><td rowspan="3"><i>p</i>-Value</td></tr><tr><td>N = 7504</td><td>N = 766</td><td>N = 6738</td></tr><tr><td>OR (95% CI)</td><td>OR (95% CI)</td><td>OR (95% CI)</td></tr... |
e5dacfbd215abbdad8acc9106bb7f36c537ad089a8659dc0e45400e787639349.png | simple | <table><tr><td>Antibody (host, clonality, Company)</td><td>Purpose</td><td>Dilution</td></tr><tr><td>FGFR1 (rabbit, polyclonal, Santa Cruz Biotechnology, CA)</td><td>IHC</td><td>1:150</td></tr><tr><td>FGFR2 (rabbit, polyclonal, Santa Cruz Biotechnology, CA)</td><td>IHC</td><td>1:150</td></tr><tr><td>FGF7 (rabbit, polyc... |
16abdcae8b6427d58acf6294fe25b8c288d0307d6f775878cbfccce185e5e248.png | complex | <table><tr><td><i>N</i> = 54</td><td colspan="4">Test site</td></tr><tr><td></td><td>A</td><td>C2</td><td>L</td><td>C1</td></tr><tr><td>Average speed (km.h<sup>−1</sup>)</td><td>23.1 ± 1.3a<sup>*</sup></td><td>21.1 ± 1.0b</td><td>21.2 ± 0.8b</td><td>22.4 ± 0.9a</td></tr><tr><td>HR (beats.mn<su... |
c72350f30549b497fec1c67d5a7d971cb6844e96c9db200ad02997d79d4451a2.png | simple | <table><tr><td>Characteristics</td><td>Controls n = 67</td><td>NSTEMI n = 38</td><td>STEMI n = 30</td></tr><tr><td>Age</td><td>66 ± 12</td><td>72 ± 15</td><td>72 ± 13</td></tr><tr><td>M/F</td><td>46/21</td><td>29/9</td><td>21/9</td></tr><tr><td>Diabetes Mellitus</td><td>8</td><td>8</td><td>4</td></tr><tr... |
b271cb0457b1b5ffb5a0e9e347c662a6813c491c1415d74b01e8e6d4e80b5711.png | simple | <table><tr><td>Raw material</td><td>Cellulose</td><td>Hemicellulose</td><td>Lignin</td><td>Ash</td></tr><tr><td>Wheat straw</td><td>44.2 (1.8)</td><td>26.5 (1.9)</td><td>22.4 (1.7)</td><td>2.8 (0.6)</td></tr><tr><td>Rice straw</td><td>36.1 (2.6)</td><td>27.2 (3.2)</td><td>19.7 (2.5)</td><td>12.1 (2.8)</td></tr><tr><td>... |
9afba184dea57942fc96ec313852f15774d9553984e735a2ec7290c4ddfc0834.png | complex | <table><tr><td colspan="4"></td><td colspan="5">Up/Down-regulated<sup>c</sup></td><td colspan="3">Regulated by</td></tr><tr><td></td><td>Gene<sup>a</sup></td><td>Enzyme<sup>b</sup></td><td>CAZy family</td><td>Δ<i>xlnR</i></td><td>Δ<i>araR</i></td><td>Δ<i>rhaR</i></td><td>Δ<i>galX</i></td><td>Δ<... |
5c1a90fe2818afd05eeb8cdbe09cf1fe9db826fda7d7b417a883bba21d744777.png | complex | <table><tr><td>Year</td><td colspan="2">Public Hospitals</td><td>Public medic patients</td></tr><tr><td></td><td>Outpatients (95% CI)</td><td># of hospitalizations</td><td></td></tr><tr><td>1918</td><td>20.11 (16.43, 25.90)</td><td>12.20 (10.59, 14.38)</td><td>32.21* (28.48, 39.82)</td></tr><tr><td>1919</td><td>14.55 (... |
fd1164931ece75cada74d5df26877423f27210e5f7ef6ebcb2c5b89332d91480.png | complex | <table><tr><td colspan="2">Surface material</td><td>SBS</td><td>ARI</td></tr><tr><td rowspan="3">Enamel</td><td>Chi-square test</td><td>18.512</td><td>11.686</td></tr><tr><td> Df</td><td>2</td><td>2</td></tr><tr><td>Asymptotic significance</td><td>0.000</td><td>0.003</td></tr><tr><td rowspan="3">SR Adoro</td><td>Chi-sq... |
54489499a55fdf9487d86a179e00ededa3e3dcfa4f19216798a609ca6ec25cde.png | complex | <table><tr><td>Year</td><td>Number of districts</td><td colspan="2">Districts reporting at least one suspected case</td><td>Number of suspected cases reported</td><td colspan="2">Blood specimens collected</td><td colspan="2">Confirmed cases</td><td>Districts with confirmed cases</td></tr><tr><td></td><td><i>n</i></td><... |
b121cc95893795522ef766b13edb6863fb6a407a2bb16326e454798f54842672.png | complex | <table><tr><td rowspan="2">Variable</td><td>Univariate</td><td colspan="2">Multivariate</td></tr><tr><td><i>p</i> value</td><td><i>p</i> value</td><td>HR (95% CI)</td></tr><tr><td>Male gender</td><td><0.0001</td><td>0.0104</td><td>1.42 (1.08–1.85)</td></tr><tr><td>Age > 55 years</td><td><0.0001</td><td>&... |
439647234f2348fe499a423928fb1e0abd4e8357d6465fb83637f700468ef418.png | simple | <table><tr><td>Type of ZnO nanostructure</td><td>Turn-on field (V μm<sup>-1</sup>)</td><td>Threshold field (V μm<sup>-1</sup>)</td><td><i>β</i></td></tr><tr><td>Leaf-like (30 min)</td><td>2.94</td><td>4.35</td><td>2,800</td></tr><tr><td>Long NWs arrays (60 min)</td><td>3.69</td><td>5.72</td><td>2,526</td... |
b7180e1705f50266cc9bcfabcaee0466d43a2ab98264b87b0a131518429493cd.png | simple | <table><tr><td>Patient no.</td><td>CSF leakage</td><td>Leakage pattern</td><td>Location of CSF leakage</td><td>Exact location of CSF leakage</td></tr><tr><td>1</td><td>+</td><td>Pseudodiverticular</td><td>Left T11/12</td><td>+</td></tr><tr><td>2</td><td>+</td><td>Gray rim</td><td>L1</td><td>+</td></tr><tr><td>3</td><td... |
2cf21bf0cbb132b0ce0512fe3344666f7f1a1bfafb0f3b19a18937884535b235.png | complex | <table><tr><td colspan="2">Variable</td><td>MetS= Yes, n (%)</td><td>COR (95% CI)</td><td><i>P-value</i></td><td>AOR (95% CI)</td><td><i>P-value</i></td></tr><tr><td rowspan="2">Gender</td><td>Men</td><td>44 (37.9)</td><td>1.00</td><td></td><td>1.00</td><td></td></tr><tr><td>women</td><td>72 (62.1)</td><td>1.6 (0.97... |
77d3421194461b57440ab105601490b917c8d5be535aa073767a283cba3064fa.png | complex | <table><tr><td rowspan="2">Instrument</td><td colspan="2">Unprepared apical area (%)</td><td colspan="2">Unprepared coronal area (%)</td></tr><tr><td>Mean ± SD</td><td>Min-Max</td><td>Mean ± SD</td><td>Min-Max</td></tr><tr><td>ProTaper Next</td><td>11.03 ± .96</td><td>10.11–12.8</td><td>55.70 ±... |
71a0f3fcdc8f3a61c6d345f8e3fc06afd30e7392315e793901893564cdc7feb5.png | simple | <table><tr><td>Heart evaluation parameters</td><td>CRT</td><td>IMRT</td></tr><tr><td>Average maximum heart dose (cGy)</td><td>5295.26</td><td>5209.87</td></tr><tr><td>Range (cGy)</td><td>4858.3–5743.8</td><td>4895.17–5862.8</td></tr><tr><td><i>P-</i>value</td><td>0.08</td><td>0.08</td></tr></table> |
e00918e7dcf1572b21b27f9a21d339ade2978aaea448ab4a51dce5e211961190.png | complex | <table><tr><td></td><td>All studies (<i>n </i>=<i> </i>102)</td><td>Randomized trials (<i>n </i>=<i> </i>25)</td><td>Nonrandomized studies (<i>n </i>=<i> </i>77)</td></tr><tr><td>Number of participants</td><td>66 386</td><td>7172</td><td>59 214</td></tr><tr><td>Age range of participants (years)</td><td>18–99</td>... |
f7a5eae316d8b0e3579dcf8e6b0d2a98593584c05accd3654a4c7fe4f6c54a9b.png | complex | <table><tr><td></td><td colspan="2">Right</td><td><i>p</i></td><td colspan="2">Left</td><td><i>p</i></td></tr><tr><td></td><td>Female</td><td>Male</td><td></td><td>Female</td><td>Male</td><td></td></tr><tr><td></td><td>Mean±SD</td><td>Mean±SD</td><td></td><td>Mean±SD</td><td>Mean±SD</td><td></td></t... |
23b0c1acba3527d9b6ffb5a87effe5036b96a8e2647c74916e3a668d1aee8ee4.png | simple | <table><tr><td>Figure #</td><td>Algorithms Used</td><td>Initial Benefit</td><td>Acquired Benefit</td><td>Lost Benefit</td><td>Overall Distance</td><td>Solution Time (s)</td></tr><tr><td>11a</td><td>Greedy TA Heuristic MP</td><td>21,000</td><td>9479</td><td>11,521</td><td>2446</td><td>1.85</td></tr><tr><td>11b</td><td>G... |
1731c8b6f31af474866153f4d6e97ca664254c811d43a2ccf0ea5019c5043c80.png | simple | <table><tr><td>Construct</td><td>Transgene</td><td>Progeny</td><td>n</td></tr><tr><td></td><td><i>ebEx498</i></td><td>92 ± 16</td><td>11</td></tr><tr><td></td><td><i>xyEx175</i></td><td>123 ± 15</td><td>10</td></tr><tr><td></td><td><i>xyEx177</i></td><td>115 ± 17</td><td>11</td></tr><tr><td></td><td><i>x... |
a83a7c7b7e975d5191c15743a6f3263a746c73733efc9d8c09af515a75b51d4f.png | simple | <table><tr><td>Epigenetic discovery</td><td>Health promotion research innovation domains</td><td>Example translational research questions</td></tr><tr><td>Individual variation in whether risk exposures negatively influence gene expression</td><td>Improving motivational potency of health communications</td><td>Evaluatin... |
3bfe5d4510d5fea31b4eef28ed1789dcb1e162ecf59754dbed010751f335a6fc.png | simple | <table><tr><td></td><td>MCAA+</td><td>MCAA−</td><td>NHS</td><td>PLG+</td></tr><tr><td>Age (mean)</td><td>61.0</td><td>59.2</td><td>58.7</td><td>59.6</td></tr><tr><td>Age (SD)</td><td>10.5</td><td>13.3</td><td>3.7</td><td>12.3</td></tr><tr><td>M:F (ratio)</td><td>33:23 (1.43)</td><td>30: 21 (1.43)</td><td>25: 15 (... |
d8f298055d3fd8949d8ab6134c61a4388b21a086019977d4ff71390d773f153e.png | simple | <table><tr><td>Patient</td><td>1</td><td>2</td><td>3</td></tr><tr><td>Age(year)</td><td>47</td><td>39</td><td>48</td></tr><tr><td>Follow-up(month)</td><td>70</td><td>54</td><td>5</td></tr><tr><td>Outcome</td><td>Favorable</td><td>Favorable</td><td>Favorable</td></tr><tr><td>Pre-operation upper-limb blood pressure(mm Hg... |
5609a019bf06a6edc758e8e15563f95850f5fae289ff12398230aa2443bd8c63.png | complex | <table><tr><td>Characteristic<sup>§</sup></td><td colspan="5">Levels of sCD40L</td></tr><tr><td></td><td colspan="2">High</td><td colspan="2">Medium-Low</td><td>p</td></tr><tr><td></td><td>No.</td><td>(%)</td><td>No.</td><td>%</td><td></td></tr><tr><td>Age:</td><td></td><td></td><td></td><td></td><td></td></tr><tr... |
30ebd356f36b9bbfe358ead734e61b2f9ed5688151b19e41a7ab56a8f1ec36ee.png | simple | <table><tr><td></td><td>df</td><td>AIC</td><td>BIC</td><td>logLik</td></tr><tr><td>m.rel.index</td><td>8</td><td>2043373</td><td>2043457</td><td>−1021678</td></tr><tr><td>m.freq.index</td><td>8</td><td>2043326</td><td>2043410</td><td>−1021655</td></tr></table> |
485c93a03463d6148659e430dfd854d05a1a5f15199cba49a8a8825b7695c100.png | simple | <table><tr><td>Time point (min)</td><td>42.5</td><td>47.5</td><td>52.5</td><td>57.5</td><td>62.5</td><td>72.5</td><td>72.5</td><td>77.5</td><td>82.5</td><td>87.5</td></tr><tr><td>Bias (%)</td><td>53</td><td>46</td><td>40</td><td>32</td><td>25</td><td>22</td><td>18</td><td>12</td><td>9</td><td>0</td></tr><tr><td>Factor ... |
6b459829f1d98533908472c6ec8a3522581da62849302bfd426afc7d49dc4fee.png | complex | <table><tr><td>Characteristic</td><td>Number (%)</td></tr><tr><td colspan="2">Age(months)</td></tr><tr><td> 0–11</td><td>166(24.3%)</td></tr><tr><td> 12–23</td><td>189(27.7%)</td></tr><tr><td> 24–35</td><td>101(14.7%)</td></tr><tr><td> 36–47</td><td>116(16.9%)</td></tr><tr><td> 48–59</td><... |
263963797e794ce3ead9b00ce3e9f99b99dab26c0e052e7438403b48f4b01faf.png | complex | <table><tr><td> </td><td>Serology (serologicmarkers)<sup><i>∗</i></sup></td><td>Endoscopy of duodenum (mucosal morphologic alternations<sup><i>∗∗</i></sup>)</td><td>Genotype (genetic markers)</td></tr><tr><td rowspan="4"> </td><td>IgA anti-tissue transglutaminase antibodies (IgA anti-tTG, IgG anti-tTG... |
e8ae8a8609c2fd0bef5d687ba3f7d1162ef5654894e6234b6eee6e03dba06adc.png | complex | <table><tr><td></td><td colspan="2">Caf1</td><td colspan="2">Ccr4</td></tr><tr><td></td><td>Gene</td><td>Synonyms</td><td>Gene</td><td>Synonyms</td></tr><tr><td><i>Saccharomyces cerevisiae</i></td><td>POP2</td><td>CAF1</td><td>CCR4</td><td>FUN27, NUT21</td></tr><tr><td><i>Schizosaccharomyces pombe</i></td><td>caf1</td>... |
458a0d1e2c182c150e73e3dc325b974122fcabf057001afc60302903abf0e302.png | complex | <table><tr><td colspan="2">Variables<sup>a</sup></td><td>High risk (n = 1170)</td><td>Not high risk (n = 563)</td><td><i>P</i> value<sup>*</sup></td></tr><tr><td colspan="2">Gender</td><td></td><td></td><td></td></tr><tr><td></td><td>Male</td><td>463 (39.6)</td><td>372 (66.1)</td><td><0.001</td></tr><tr><td></td><td... |
cb5dbc3068f2ffdff9330bb1de87d0678e2e27f8a5cb194e7f1effdbfd628713.png | simple | <table><tr><td>Factors</td><td>Have you ever attended VCT (N (%))</td><td></td><td></td><td></td></tr><tr><td></td><td>Yes</td><td>No</td><td>χ<sup>2</sup></td><td>p-value</td></tr><tr><td>Religion</td><td></td><td></td><td></td><td></td></tr><tr><td>Protestant</td><td>36(29.3)</td><td>87(70.7)</td><td>5.6</td><td... |
80eb5ade60a72ce9cae6eeb5e47f5e475f0e02fbdb0447f94bea58f3e9661bb9.png | simple | <table><tr><td></td><td>Total</td></tr><tr><td>No. of patients</td><td>394</td></tr><tr><td>Age (years)</td><td></td></tr><tr><td> Mean ± SD</td><td>57.0 ± 12.8</td></tr><tr><td> Range</td><td>28-94</td></tr><tr><td>Tumor size (cm)</td><td></td></tr><tr><td> ≤2.0</td><td>197 (50.0%)</td></tr><tr><td> 2.... |
4eb6feafbc39ac3cbf6c5960b3039c83fd5ad045ff2e44a0c784e3ce682fe224.png | simple | <table><tr><td>Patient number</td><td>Patient age</td><td>Early or late infection</td><td>Procedure</td><td>Time after first washout that NPWT was applied</td><td>Duration of NPWT</td><td>Number of NPWT changes</td><td>Long-term outcome</td></tr><tr><td>1</td><td>17 years</td><td>Late</td><td>Corrective surgery for sev... |
37ba41baf7e871f5ac5d3ce2ddf958a739162e230c352122569fe846ee6ad9c5.png | simple | <table><tr><td>MAA Category</td><td>Commercial Agreement</td><td>Payment for Performance Agreement</td><td>Coverage with Evidence Development</td></tr><tr><td>Contract type</td><td>• Discount-based contract</td><td>• Permanent risk-shifting agreement (outcomes guarantee/insurance) applied on a per-patient b... |
79fc1464ddbea81683cf8c1a44051e6ea46857236ad6aad00fc47497d0846e9a.png | simple | <table><tr><td></td><td>All patients</td><td>Cases</td><td>Control</td></tr><tr><td>Samples</td><td>10,324</td><td>6,564</td><td>5,072<sup>b</sup></td></tr><tr><td>Identified CNVs</td><td>14,226<sup>a</sup></td><td>9,186</td><td>495,916</td></tr><tr><td>Type of CNVs:</td><td></td><td></td><td></td></tr><tr><td>Loss</td... |
04929abbdddd8373905cf506ae23ad50e313e9c673116f652d477ad9c81a9e98.png | complex | <table><tr><td rowspan="2"> </td><td colspan="3">Flexion</td><td colspan="3">Extension</td></tr><tr><td>Pre-operation</td><td>13 months after the operation</td><td>18 months after the operation</td><td>Pre-operation</td><td>13 months after the operation</td><td>18 months after the operation</td></tr><tr><td>Left hip</t... |
f5285e92dbbfa8a398fba89abd500ccff30b8003ad7f28896855d878bbd20134.png | simple | <table><tr><td>Trait</td><td>Description (ability assessed)</td><td>CLDRC-RD (564)</td><td>UK-RD (958)</td><td>SLIC (498)</td><td>CLDRC-ADHD (163)</td></tr><tr><td>WRead</td><td>Reading real words</td><td>x (0.918)</td><td>x (0.918)</td><td>x (0.902)</td><td>x (0.871)</td></tr><tr><td>WSpell</td><td>Spelling real words... |
227265bbd9a416bd00c19e002339c49f7310e830a12c705f56631f9c3e32bf66.png | simple | <table><tr><td> </td><td><i>T-cell development</i></td><td><i>Naive T-cell homeostasis</i></td><td><i>T-cell activation</i></td><td><i>T-cell differentiation</i></td><td><i>T-cell memory</i></td><td><i>References</i></td></tr><tr><td><i>Slc7a5</i><sup>–/–</sup> mice</td><td>No</td><td>No</td><td>T-cell acti... |
3229bac2195d4ebc7500856bdbe81d3d66d4e9f733e5c938b3b037e367af6436.png | simple | <table><tr><td>Term</td><td>Number of medications</td><td>Number of studies</td><td>References</td></tr><tr><td>Polypharmacy</td><td>≥ 2 for > 240 days (long term)</td><td>1</td><td>[101]</td></tr><tr><td></td><td>≥ 5 medications in the same month</td><td>1</td><td>[103]</td></tr><tr><td></td><td>> 5 ... |
931d390c5553904bf414c05b05cb9ba4580a527387764494ffa7bc12da06ddf2.png | simple | <table><tr><td>Category</td><td>Treatment group (<i>n</i> = 16)</td><td>Control group (<i>n</i> = 12)</td><td><i>P</i> value</td></tr><tr><td>Age (months)</td><td>136 (93–216)</td><td>140 (96–176)</td><td>0.82</td></tr><tr><td>Weight (kgs)</td><td>7.70 (1.44–27.82)</td><td>4.75 (1.63–29.09)</td>... |
0914f4a15df0cd49d7a9d9e73dfe9af02af7dcece8b853e921daf5e2215ab7e9.png | simple | <table><tr><td>Water Microbe</td><td>Amplified NuclearRibosomal Regions</td><td>Primer Sets (from 5' to 3')</td><td>PCR Program</td></tr><tr><td>Bacteria [19,20]</td><td>16S rRNA V4-V5 region</td><td>515F: GTGCCAGCMGCCGCGGTAA907R: CCGTCAATTCCTTTGAGTTT</td><td>95°C for 2 min, 30 cycles of 95°C for 30 s, 55... |
c28f769c56f37a4ddbe0ea5afe53e41e8ec11d04a03b526266290c8d23b37f65.png | simple | <table><tr><td>whale</td><td>age/sex</td><td>year</td><td>tag duration (days)</td><td>min. latitude (° S)</td><td>max. SST (°C)</td></tr><tr><td>1</td><td>adult/female</td><td>2009</td><td>08 Jan–16 Jan (9)</td><td>64</td><td>2.3</td></tr><tr><td>2</td><td>adult/female</td><td>2009</td><td>14 Jan–... |
7465703eaf50cec176937fec5ed5c1b31501568dc6a463cdb15aea6fca3e6239.png | simple | <table><tr><td>Age (yrs)</td><td>Weight (kg)</td><td>Gender</td><td>Ethnicity</td><td>Indication</td><td>Target INR</td><td>Drug Interaction(s)</td><td>Therapeutic warfarin dose (mg/d)</td><td>Reference</td></tr><tr><td>69</td><td>79.8</td><td>Female </td><td>Japanese</td><td>AFib</td><td>1.5–20</td><td>NR</td><t... |
60a84dd3c0f72497af355c2146c73492341c2c66a93d5281ace6bcce69af006e.png | complex | <table><tr><td></td><td>N</td><td>%</td></tr><tr><td>Clozapine</td><td>9</td><td>39</td></tr><tr><td>Other antipsychotics</td><td>14</td><td>61</td></tr><tr><td> Traditional antipsychotics</td><td>6</td><td>26</td></tr><tr><td> Atypical antipsychotics</td><td>8</td><td>35</td></tr><tr><td>Mood stabilizers</td><td>5</td... |
c1dc7e27f960418fe1009d2cdceb319ed569e5dbc952fcf3220bb79c3873a60c.png | complex | <table><tr><td rowspan="2">Barrier</td><td colspan="2">1<sup>st</sup> Barrier</td><td colspan="2">2<sup>nd</sup> Barrier</td><td colspan="2">3<sup>rd</sup> Barrier</td><td>Total</td></tr><tr><td>Freq</td><td>%</td><td>Freq</td><td>%</td><td>Freq</td><td>%</td><td><i>N</i></td></tr><tr><td>Delay before care is received<... |
beef9b9ee451acf4bfe5fa1c66f7cc9b8622d6640a15b29b13dc6d6b941de55e.png | simple | <table><tr><td>Variable</td><td>Unadjusted</td><td>Adjusted for CRP/AGP <sup>2</sup></td></tr><tr><td>Participants (<i>n</i>) <sup>3</sup></td><td>770</td><td>770</td></tr><tr><td>Hb concentration, g/dL <sup>4</sup></td><td>9.6 (9.5,9.8)</td><td>-</td></tr><tr><td>Anemia, Hb < 10.5 g/dL (2nd trimester) or 11.0 g/dL ... |
e347910cf9ef5315c661266d76a6e15caba4e9870a7ec300776fb401bec454fe.png | complex | <table><tr><td rowspan="2">Country</td><td rowspan="2">Year of data collection</td><td colspan="6">Male</td><td colspan="8">Female</td></tr><tr><td>lung</td><td>stomach</td><td>large bowel</td><td>prostate</td><td>kidney</td><td>urinary bladder</td><td>lung</td><td>stomach</td><td>large bowel</td><td>breast</td><td>cer... |
f4d2eeab02360850a1151f154ab38444f0a7524a58f448dbda8fa95e4b325e95.png | complex | <table><tr><td>Parameters</td><td>Lead (Pb)</td><td>Cadmium (Cd)</td><td>Zinc (Zn)</td><td>Iron (Fe)</td><td>References</td></tr><tr><td>Water concentration (ppm)</td><td>0.33 ± 0.03</td><td>0.02 ± 0.00*</td><td>0.01 ± 0.00**</td><td>2.61 ± 0.07**</td><td>This study</td></tr><tr><td>Liver concentrat... |
0e559518f626ffc1660d1446264f3fb46fa135e211bc85f9dfaa73a63e8e4c50.png | complex | <table><tr><td>Factor</td><td colspan="2">Prokaryotic community (<i>P</i>/R)</td><td></td><td colspan="2">Fungal community (<i>P</i>/R)</td></tr><tr><td></td><td>Chao1 (Richness)</td><td>Shannon</td><td></td><td>Chao1 (Richness)</td><td>Shannon</td></tr><tr><td>Na</td><td>0.489/-0.006</td><td>0.592/-0.033</td><td></td>... |
7bdc4d8018002a3f3caac8535d9e206c68b6e8566d828037c6a37d3ef2e80424.png | simple | <table><tr><td>Fatty acid</td><td>Overall <i>N</i> = 3196</td><td>Male <i>N</i> = 1434</td><td>Female <i>N</i> = 1762</td><td><i>P</i> value*</td></tr><tr><td>Myristic, C14:0</td><td>0.31 (0.08)</td><td>0.29 (0.07)</td><td>0.32 (0.09)</td><td><0.0001</td></tr><tr><td>Palmitic, C16:0</td><td>21.29 (1.24)</td><td>21.2... |
9997778607d72ceb7ab82835009ffbac248ce2b073822896418a4e3db5eeb659.png | simple | <table><tr><td>Factor</td><td>Effect on efficiency</td><td>Implications</td></tr><tr><td>Decreased morale</td><td>Decrease</td><td>Increase staff support and supervision, plan for retention, access to ART</td></tr><tr><td>Increased experience</td><td>Increase</td><td>Plan to increase retention to keep experienced staff... |
d892e0c31b84afedcd8e2e13edcd1abf97761462d9a7793085acd751754d8f47.png | complex | <table><tr><td></td><td colspan="3">Number</td></tr><tr><td></td><td>Round 1</td><td>Round 2</td><td>Round 3</td></tr><tr><td>Participant response rate</td><td>34/49 (70%)</td><td>33/34 (97%)</td><td>32/33 (97%)</td></tr><tr><td>Gender</td><td></td><td></td><td></td></tr><tr><td> Male</td><td>8 (23.5%)</td><td>8 (24.2%... |
4243adae04103dba490259a59cb47fe757faf9ec1ec63ec55c46267bafa30055.png | simple | <table><tr><td>Compounds</td><td><i>E</i><sub>e</sub>/au</td><td>(Δ<i>E</i><sub>b</sub>) kcal/mol</td><td><i>E</i><sub>BSSE</sub></td><td>(Δ<i>E</i><sub>b-bsse</sub>) kcal/mol</td><td><i>E</i><sub>c</sub></td><td>(Δ<i>E</i><sub>cb</sub>) kcal/mol</td><td><i>H</i>\au</td><td>Δ<i>H</i> kcal/mol</td></... |
a5fff2874247418b90506c571ede32e808c2a1f4e3984cacfe224f7c0e000f79.png | simple | <table><tr><td></td><td>A/CPA patients</td><td>Pure APA patients</td><td><i>P</i> value</td></tr><tr><td>Number of cases</td><td>22</td><td>392</td><td></td></tr><tr><td>Age (years)</td><td>40.32 ± 6.37</td><td>38.37 ± 7.76</td><td>0.1255</td></tr><tr><td>Age range (years)</td><td>26–51</td><td>19–... |
929778d428d4c570632bbd69c9e1e989db0d6bc286344344e305be5b1eab21f6.png | complex | <table><tr><td rowspan="2">Error type and antimicrobial</td><td rowspan="2">Organism</td><td rowspan="2">No. of errors</td><td colspan="2">MIC<sup><i>a</i></sup></td><td colspan="2">AST result<sup><i>b</i></sup></td><td colspan="2">Breakpoint<sup><i>a</i></sup></td><td colspan="2">Reportable range<sup><i>a</i></sup></t... |
091d042282da17f2ce87a05ebd1c805ce7ad00a23a143417ea9c2b7f7eb42a77.png | complex | <table><tr><td></td><td>Target population (<i>n</i> = 5)</td><td>Key stakeholders (<i>n</i> = 5)</td></tr><tr><td>Gender</td><td>Male (4)</td><td>Male (3)</td></tr><tr><td>Age</td><td>21–34 years 
(mean: 26 years)</td><td>23–38 years 
(mean: 29 years)</td></tr><tr><td rowspan="4">Educational sta... |
9671248b31598833e9ce5af8c9810a2d92ae27260ba5db866e0262906c65d357.png | simple | <table><tr><td> </td><td>No. (%)</td></tr><tr><td>State of health</td><td> </td></tr><tr><td>Good</td><td>349 (37.0)</td></tr><tr><td>Poor</td><td>595 (63.0)</td></tr><tr><td>Emotional status</td><td> </td></tr><tr><td>Blank</td><td>144 (15.3)</td></tr><tr><td>Unhappy (ever)</td><td>99 (10.5)</td></tr><tr><td>Ordinary<... |
53cda5a4147d2039c24fe6b2733ac8017a4f49b4b839f12ddc1292ab9045a5cc.png | complex | <table><tr><td rowspan="2"></td><td>Total Median Costs</td><td></td><td></td><td></td><td>MRI</td><td></td><td>No MRI</td><td></td></tr><tr><td colspan="4">(<i>N</i> = 53,653)</td><td colspan="2">(<i>N</i> = 10,776)</td><td colspan="2">(<i>N</i> = 42,877)</td></tr><tr><td>Characteristics<sup>b</sup> of women</td><td>N<... |
39f134e0b5c80700b46267f05160cc8ca5a1953e43113bb81429f7a75f8457b6.png | simple | <table><tr><td>Reason of Intake</td><td>Cat</td><td>Dog</td></tr><tr><td>Stray</td><td>100 (80.6%)</td><td>58 (47.5%)</td></tr><tr><td>People Issues (allergic, relocating, etc.)</td><td>5 (4.0%)</td><td>16 (13.1%)</td></tr><tr><td>Deceased Caretaker</td><td>3 (2.4%)</td><td>1 (0.8%)</td></tr><tr><td>Negligence</td><td>... |
7385c8fe1af7e5548cc3311b922a637e7b721de44e136d648434dbdcc96836b2.png | simple | <table><tr><td>Time steps</td><td>Experiment-1</td><td>Experiment-2</td><td>Experiment-3</td><td>Experiment-4</td></tr><tr><td><i>t</i><sub>0</sub></td><td>75.12%</td><td>92.80%</td><td>55.02%</td><td>67.90%</td></tr><tr><td><i>t</i><sub>1</sub></td><td>78.07%</td><td>95.40%</td><td>80.01%</td><td>72.42%</td></tr><tr><... |
0d4061eb372ecbcf9be5875c374e79c96c424a1cacb8f57bd30394ee48d890ff.png | complex | <table><tr><td>Target</td><td>Species</td><td>Dilution</td><td>Reference</td></tr><tr><td colspan="4">Primary antibodies</td></tr><tr><td> Nrf2</td><td>Rabbit</td><td>1:100</td><td>ab31163; Abcam, UK</td></tr><tr><td> AhR</td><td>Rabbit</td><td>1:200</td><td>sc-5579; H-211; Santa Cruz, Heidelberg, Germany</td></tr><tr>... |
79409dac05db8ada4d3d6f873f18a11ff09224f500e4d32b824c6c03c0c836e6.png | complex | <table><tr><td> </td><td colspan="2">1a</td><td> </td><td colspan="2">7b</td></tr><tr><td>Position</td><td><i>δ</i><sub>C</sub></td><td><i>δ</i><sub>H</sub> (<i>J</i> Hz)</td><td>Position</td><td><i>δ</i><sub>C</sub></td><td><i>δ</i><sub>H</sub> (<i>J</i> Hz)</td></tr><tr><td>1a</td><td>43.8</td><td... |
7ec2619cc8d54d69ebc622cbc55b254a8e871d93b6ed9fef88026a398acd4165.png | simple | <table><tr><td>Tumor and normal cells</td><td>Cis-3M-RESIC<sub>50</sub> (μM)<sup>*</sup></td><td>ResveratrolIC<sub>50</sub> (μM)<sup>*</sup></td></tr><tr><td>Unstimulated human peripheral T cells</td><td>>10.0</td><td>N.D</td></tr><tr><td>PHA-stimulated human peripheral T cells<sup>**</sup></td><td>0.23</t... |
d40bfefd7ccad9ceab6e894d6ec8b99dd6b75fac022a1275cf1633cbddb99af3.png | simple | <table><tr><td>Variable</td><td>Categories</td><td>Unadjusted Odd ratio (CI)</td></tr><tr><td>Fistula size</td><td>Large (> 3 cm)</td><td>5.33(0.93-30.50)</td></tr><tr><td></td><td>Medium (1-3 cm)</td><td>0.63(1.39-2.86)</td></tr><tr><td></td><td>Small (< 3 cm)</td><td>1</td></tr><tr><td>Level of vaginal scarring... |
bdc9ec0d0cd0ce381b73aff8a30be0b228233e8b0f1dc42daeceec476e71fd4f.png | complex | <table><tr><td></td><td>Adult <i>n</i> (%) (<i>n</i> = 186)<sup>a</sup></td><td>Paediatric <i>n</i> (%) (<i>n</i> = 17)<sup>a</sup></td><td><i>p</i>-value</td></tr><tr><td>Pulmonary TB</td><td>125 (67)</td><td>14 (82)</td><td>0.198</td></tr><tr><td> Multidrug-resistant TB</td><td>7 (6)</td><td>2 (14)</td><td>0.099</td>... |
c1c0c92e3c70740dc067896ea690521b088f751521ed71334965fb3f7694b899.png | simple | <table><tr><td> ISTH score</td><td>Predicted score from PT</td><td>Predicted score from PT + APTT</td><td>Predicted score from PT/APTT</td></tr><tr><td>2</td><td>3.44</td><td>3.37</td><td>3.70</td></tr><tr><td>2</td><td>3.48</td><td>3.49</td><td>3.43</td></tr><tr><td>2</td><td>3.34</td><td>3.31</td><td>3.29</td></tr><t... |
49285aa3003552accc7dbcd8b5d251fd4308d6bc784eb74eb5e0900cf0a59614.png | complex | <table><tr><td>Scale</td><td colspan="3">Men</td><td colspan="3">Women</td><td><i>d</i> (Men-Women)</td></tr><tr><td></td><td>α</td><td><i>M</i></td><td><i>SD</i></td><td>α</td><td><i>M</i></td><td><i>SD</i></td><td></td></tr><tr><td>Vigor</td><td>0.89</td><td>3.03</td><td>0.89</td><td>0.88</td><td>2.87</td><... |
9ad4cc74acef76c4b6d88aa3241b4719fcc40379cfd225d90f0723ecfd213c76.png | complex | <table><tr><td colspan="2"> </td><td>All participants(<i>N</i> = 2,467)</td></tr><tr><td colspan="2">Age, years</td><td>58.3 (15.7)</td></tr><tr><td colspan="2">Sex, women, <i>n</i></td><td>1,438 (58.3%)</td></tr><tr><td colspan="2">Regular exercise,<sup>a</sup><i>n</i></td><td>831 (33.8%)</td></tr><tr><td>Smoking</td>... |
21b25826035432386722bd00b194f3d301024c386e263f06d6010144a911c70d.png | simple | <table><tr><td>Characteristic</td><td>No. of participants (<i>n</i> = 15)</td></tr><tr><td>Age [median (range)]</td><td>47 (33–59)</td></tr><tr><td>Sex</td><td></td></tr><tr><td>Male</td><td>8</td></tr><tr><td>Female</td><td>7</td></tr><tr><td>Ethnicity</td><td></td></tr><tr><td>White British</td><td>13</td></tr>... |
0f8f8eba032d6ac99c875a2af0d95de31ad4e835caa0054ca30b92feccf5dc25.png | complex | <table><tr><td rowspan="2"></td><td colspan="2">Ethiopia</td><td colspan="2">Kenya</td></tr><tr><td>Urban</td><td>Rural</td><td>Urban</td><td>Rural</td></tr><tr><td>Age</td><td></td><td></td><td></td><td></td></tr><tr><td> 15–24</td><td>15.9</td><td>15.9</td><td>12.5</td><td>10.3</td></tr><tr><td> 25–34</td... |
65743b0ce55a789cc9169a3b02acd0f88f574a30dc5c4c3cedb6dcbdc4550e28.png | complex | <table><tr><td>Data</td><td>Characteristics</td><td>Description</td></tr><tr><td rowspan="3">Classes of deprivation</td><td>Group 1: low deprivation</td><td>Census block with high median income, low proportion of households without a car, low proportion with non-owner-occupied primary residences</td></tr><tr><td>Group ... |
ca07b1f1fa34fb65011864367c298872676e891c63eed51a8d97c2a0d6da20da.png | complex | <table><tr><td></td><td></td><td></td><td colspan="2">95% Confidence Interval for odds</td></tr><tr><td></td><td>P value</td><td>OR</td><td>Lower</td><td>Upper</td></tr><tr><td>Gender(female)</td><td></td><td></td><td>1.259</td><td>5.725</td></tr><tr><td>Jobless</td><td><.001</td><td>1.870</td><td>1.412</td><td>2.47... |
c8eaf89bb451435fc6376374d0370e126a01eebe043598efb32bb86835c342c5.png | complex | <table><tr><td></td><td colspan="4">Position at foot contact (deg)</td></tr><tr><td></td><td>Flexion</td><td>Ext. tibial rot.</td><td colspan="2">Varus</td></tr><tr><td>ICC</td><td>0.93</td><td>0.94</td><td colspan="2">0.95</td></tr><tr><td>SEM (deg)</td><td>1.80</td><td>1.42</td><td colspan="2">0.61</td></tr><tr><td><... |
26c8d51ee97393aa2429bc008432a43f191fec1b403ff520546fd64a33757bf5.png | simple | <table><tr><td></td><td>Metric</td><td><i>F</i></td><td><i>R</i><sup>2</sup></td><td><i>p</i> value*</td></tr><tr><td>HC (<i>n</i> = 29)vsRTT (<i>n</i> = 50)</td><td>Unweighted UniFrac</td><td>6.84</td><td>0.08</td><td>≤0.003</td></tr><tr><td></td><td>Weighted UniFrac</td><td>15.6</td><td>0.16</td><td>≤0.00... |
4f9dc11712b09d0a7d6e90e54df26f9910a0c6896e4bad3fc7185527bb585da7.png | complex | <table><tr><td></td><td></td><td>CECA22*</td><td>CECA10</td><td>CECA6</td><td>CECA4</td></tr><tr><td colspan="2">N° of items</td><td>22</td><td>10</td><td>6</td><td>4</td></tr><tr><td colspan="2">Scoring distribution</td><td></td><td></td><td></td><td></td></tr><tr><td colspan="2">Valid observations</td><td>132</t... |
bde03731d9c8752a3742857fd39619c1930069c52e7a10802356251891cbda84.png | simple | <table><tr><td></td><td>Insomnia (<i>N</i> = 17)</td><td>Controls (<i>N</i> = 15)</td><td><i>p</i>-values</td></tr><tr><td>HbA1c (%)</td><td>5.3 (0.3)</td><td>5.4 (0.3)</td><td>>0.05</td></tr><tr><td>Fasting blood glucose (mg/dl)</td><td>97.6 (8.2)</td><td>96.3 (10.3)</td><td>>0.05</td></tr><tr><td>Blood glucose ... |
a66f46c43900efdb7ca3ab1df1d49aa668bd745844b7831549e85b1243043223.png | simple | <table><tr><td>Toxicity</td><td>Grade</td><td>ACRT</td><td>STRT1</td><td>STRT2</td><td>Total</td><td><i>p</i>-value</td></tr><tr><td></td><td></td><td>(45 Gy)</td><td>(60-63 Gy)</td><td>(> 63 Gy)</td><td></td><td></td></tr><tr><td></td><td></td><td>n = 154</td><td>n = 99</td><td>n = 239</td><td></td><td></td></tr><t... |
e1d1f80626cf58259487b9ebf1578afd8bb947aa1feab4f51d40d5cb36fc8b38.png | simple | <table><tr><td>S. No</td><td>Lubricant</td><td>Speed (kmph)</td><td>Load (N)</td></tr><tr><td>1</td><td>Racer-4</td><td>40-60</td><td>10-50</td></tr><tr><td>2</td><td>Racer-4 + 0.05% Cu</td><td>40-60</td><td>20-80</td></tr><tr><td>3</td><td>Racer-4 + 0.1% Cu</td><td>40-60</td><td>20-80</td></tr><tr><td>4</td><td>Racer-... |
d0455f7f1045812c43caf3caa0253c58a45911f59647bce413045538321b6ab1.png | complex | <table><tr><td>Factors</td><td colspan="2">Simple regression</td><td colspan="3">Multiple regression</td></tr><tr><td> </td><td>Unstandardizedcoefficient(B)</td><td>P value</td><td>Unstandardizedcoefficient(B)</td><td>Standardizedcoefficient(beta)</td><td>P value</td></tr><tr><td>Gly1057Asp polymorphism in IRS-2</td><t... |
0ad0c0d2dad0e58b7167353448a1d3e405d0dabdbdef6d875875a6a0c1ebdd06.png | complex | <table><tr><td rowspan="3">Spice</td><td colspan="6">Frequency of dishes prepared</td></tr><tr><td colspan="2">Daily</td><td colspan="2">Weekly</td><td colspan="2">Monthly</td></tr><tr><td>N</td><td>Intake mean ± S.D (Median)</td><td>N</td><td>Intake mean ± S.D (Median)</td><td>N</td><td>Intake mean ± S.... |
1f704a92d2e1e9cca9fe78076d42c9e96bcb29311ae00c82d502421fe9b7beed.png | simple | <table><tr><td> </td><td>NC</td><td>MCI</td><td>AD</td></tr><tr><td>NC</td><td>15/16</td><td>1/1</td><td>0/0</td></tr><tr><td>MCI</td><td>2/1</td><td>14/16</td><td>3/1</td></tr><tr><td>AD</td><td>0/0</td><td>3/1</td><td>14/16</td></tr></table> |
28ab9395f57c2ef3d41d97c508f9b209023c09a236eaea00f557f7f15ab8c6c7.png | complex | <table><tr><td>Category</td><td>Part A</td><td>Part B</td><td>Part C</td><td>Total</td></tr><tr><td rowspan="2">Preferred Term</td><td>(<i>N</i> = 12)</td><td>(<i>N</i> = 10)</td><td>(<i>N</i> = 10)</td><td>(<i>N</i> = 32)</td></tr><tr><td>N (%)</td><td>N (%)</td><td>N (%)</td><td>N (%)</td></tr><tr><td>Subjects with A... |
f92145ebeb69407c1ab817972590e5d45a0807f3bd377d0d020c0e733f627ae4.png | simple | <table><tr><td></td><td>Phe-free milk</td><td>Phe-free amino acid powder (A-1)</td><td>Low Phe peptide powder (MP-11)</td></tr><tr><td>Protein (g)</td><td>15.8</td><td>93.7</td><td>75</td></tr><tr><td>Fat (g)</td><td>17.1</td><td>0</td><td>0</td></tr><tr><td>Carbohydrate (g)</td><td>60.4</td><td>0</td><td>7.2</td></tr>... |
b0917f259b6ef369df22d690199c689e07a5579cac44674ec5ede18da4e91ce3.png | complex | <table><tr><td> </td><td colspan="2">Prevalence per 10,000</td><td colspan="2">Crude incidence per 10,000</td><td colspan="2">Mortality per 100,000</td><td colspan="2">Fatality per 1,000</td></tr><tr><td>Age</td><td>Rate</td><td>C.I. 95%</td><td>Rate</td><td>C.I. 95%</td><td>Rate</td><td>C.I. 95%</td><td>Rate</td><td>C... |
2e189bc0a8b3f3f04b1f3dd5ff3a8883bb820c07a6db6148647e6f49596378f2.png | complex | <table><tr><td rowspan="2">Compound Administered</td><td rowspan="2">Subject ID</td><td colspan="2"><i>R-</i>baclofen (ng/mL) </td><td colspan="2"><i>S-</i>baclofen (ng/mL) </td><td colspan="2"><i>S-</i>M1 (ng/mL) </td></tr><tr><td>Plasma</td><td>Urine</td><td>Plasma</td><td>Urine</td><td>Plasma</td><td>Urine</td></tr>... |
01e0785d8520e8d4c70ef62618b45678eb6a1bda0a495dbba058d91b5388c06e.png | simple | <table><tr><td></td><td>25 JIA patientswith secondary LOE</td><td>28 JIA patientswithout secondary LOE</td></tr><tr><td>median age (range)</td><td>14.4 (6.0-27.0) years</td><td>13.8 (7.6-21.5) years</td></tr><tr><td>Sex</td><td>21 female, 4 male</td><td>18 female, 10 male</td></tr><tr><td>median ADM dose (range)</td><t... |
6a364e70dd1969dad09472c87f37afe3b4889f61f9928ae10c62bb8d5176c6ff.png | simple | <table><tr><td>ETIOLOGY</td><td>NO. OF PATIENTS</td><td>PERCENTAGE</td></tr><tr><td>ONCOLOGICAL RES.</td><td>75</td><td>42.1%</td></tr><tr><td>TMJ ANKYLOSIS</td><td>35</td><td>19.6%</td></tr><tr><td>POST-TRAUMATIC</td><td>44</td><td>24.7%</td></tr><tr><td>OSTEOMYELITIS OF MANDIBLE</td><td>24</td><td>13.5%</td></tr><tr>... |
3bb89bcba0539bd0b616fae3ac782015caea7b6a62dbdea091e9ef8510c5af4f.png | simple | <table><tr><td>Factor</td><td>Estimate</td><td>SE</td><td>Chi-square</td><td><i>P</i> value</td></tr><tr><td>F14</td><td>0.0197</td><td>0.0184</td><td>1.14</td><td>0.2857</td></tr><tr><td>F3</td><td>0.1558</td><td>0.0304</td><td>26.34</td><td><0.0001</td></tr><tr><td>F9</td><td>0.0498</td><td>0.0185</td><td>7.22</td... |
79ee8e401c979524f2174a03629bb6ee38aee278bae8bfb2b96473d24ba97ebf.png | complex | <table><tr><td rowspan="2"></td><td colspan="2">PM6</td><td colspan="2">PM7</td></tr><tr><td>E (kcal/mol)</td><td>∆E (kcal/mol)</td><td>E (kcal/mol)</td><td>∆E (kcal/mol)</td></tr><tr><td><i>Isolated molecule</i></td><td></td><td></td><td></td><td></td></tr><tr><td>Plumbagin</td><td>−84.56</td><td></t... |
4e38fb8255717b7151af9fd219fbacda737d7860013ba2e439413192bd8bfae3.png | complex | <table><tr><td> </td><td><i>Control</i></td><td><i>Intervention</i></td><td><i>Comparison</i></td><td><i>Treatment effect</i></td><td><i>P value</i></td></tr><tr><td>Maternal</td><td>n = 75</td><td>n = 79</td><td> </td><td>(95% CI)</td><td> </td></tr><tr><td>GDM</td><td>24 (32%)</td><td>22 (28%)</td><td>Risk difference... |
bb93a2ed6ac8034ba5626f2d54ea43315954f29e10dc23cb9c23931d69d88575.png | simple | <table><tr><td>Green alga/land plant</td><td>Size (bp)</td><td>IR size (bp)</td><td>Genes (no.) <sup>a</sup></td><td>Introns (no.) <sup>b</sup></td><td>GenBank accession no.</td></tr><tr><td>Charophyceae</td><td></td><td></td><td></td><td></td><td></td></tr><tr><td><i>Chara vulgaris</i></td><td>184,933</td><td>10,919</... |
4726a7749ed05fac64b7a00b16b63edcb8474a09416406486c3989f1c40865af.png | simple | <table><tr><td></td><td>N-starved cells</td><td>P-starved cells</td></tr><tr><td>Total sequences collected</td><td>2,259,219</td><td>1,501,972</td></tr><tr><td>Total signatures</td><td>44,779</td><td>27,722</td></tr><tr><td>Reliable, significant signatures</td><td>27,217</td><td>20,161</td></tr><tr><td>Signatures uniqu... |
3458bc2bf3406d0cf5e599a6c9345768822978e835d08c400a1490aef1d720d2.png | simple | <table><tr><td></td><td>All patients (<i>n =</i> 129)</td><td>Trastuzumab-resistant patient (<i>n =</i> 32)</td><td>Trastuzumab-sensitive patients (<i>n =</i> 97)</td><td><i>P</i>-value</td></tr><tr><td>Age at diagnosis</td><td>59 (30-84)</td><td>60 (30-82)</td><td>58 (32-84)</td><td>0.623</td></tr><tr><td>Sex</td><td>... |
ec52e56d699489f62246126c30ba81107ed7e26921c4e60f9d82bb19979b6478.png | simple | <table><tr><td></td><td>CKD (<i>n</i>= 6)</td><td>CKD + pravastatin (<i>n</i>= 5)</td></tr><tr><td>Focal glomerulosclerosis (%)</td><td></td><td></td></tr><tr><td> Normal</td><td>32.9 ± 7.6</td><td>23.4 ± 13.1</td></tr><tr><td> Partial</td><td>48.1 ± 10.6</td><td>62.7 ± 10.4</td></tr><tr><td> Total<... |
8c042be04cfcbdfe8303b20069e72ee8f551034c1fcc9512ff23b13b33b2afa7.png | complex | <table><tr><td>Dependent variables:</td><td colspan="2">Complaints of generalised anxiety</td></tr><tr><td></td><td>MEN</td><td>WOMEN</td></tr><tr><td></td><td>B</td><td>B</td></tr><tr><td>Intercept</td><td>-0.027 ***</td><td>-0.004</td></tr><tr><td>Contextual effects</td><td></td><td></td></tr><tr><td>Unemployment rat... |
74d200590c3ca1ffb3a787fa3d8dc0d5e130fc4eb37b98c32f7a256587f624e5.png | simple | <table><tr><td>Year</td><td>First Author</td><td>No</td><td>Sex</td><td>Age</td><td>Site</td><td>Complications</td><td>Treatment</td><td>Incision</td><td>LOS (days)</td></tr><tr><td>1991 [13]</td><td>Hale</td><td>22</td><td>M</td><td>85</td><td>Sigmoid</td><td>Incarceration</td><td>Hartmann’s + intra-abdominal in... |
ab132861fa58245909a6e4bed997205f54e00913ff46f5332ed2a53c1b54acbf.png | complex | <table><tr><td></td><td>Normotensive pregnancy (<i>n</i> = 3183)</td><td>Gestational hypertension (<i>n</i> = 145) Beta (95% CI)</td><td><i>P</i> value</td><td>Pre-eclampsia (<i>n</i> = 63) Beta (95% CI)</td><td><i>P</i> value</td></tr><tr><td colspan="6">Retinal arteriolar caliber (SDS)</td></tr><tr><td> Full model</t... |
42680961659dac59e806ee0123b21dbf4f937d94eb9c3464598c90a57e2510ea.png | complex | <table><tr><td rowspan="2">Medium</td><td colspan="5">Time</td></tr><tr><td>0 day</td><td>1 day</td><td>3 days</td><td>5 days</td><td>7 days</td></tr><tr><td>Water</td><td>208.7 ± 12.6</td><td>214.2 ± 10.1</td><td>217.7 ± 9.5</td><td>224.4 ± 10.6</td><td>227.8 ± 13.4</td></tr><tr><td>PBS plus 1... |
d67d7d72921715cd03914076708168d36d3d598a24d008ab27c2af03af91cb56.png | complex | <table><tr><td>Cell lines</td><td colspan="4">IC50</td></tr><tr><td></td><td>GEM (μM)</td><td>OSI-027 (μM)</td><td>OSI-027 (μM) + GEM (μM)</td><td>Interaction</td></tr><tr><td>Panc-1</td><td>14.79 (10.34 to 19.20)</td><td>21.93 (17.37 to 26.48)</td><td>OSI8.951 (8.309 to 9.594)GEM0.8951 (0.8309 to 0... |
4413ef9a1fe09853a4c51393d92cd339a0f54f3336cd8914cb0c9526d2361b2c.png | simple | <table><tr><td>Statistical value </td><td>DR: VC</td><td>DR: RMSSD</td><td>DR: max-min</td><td>VR</td><td>Rest: VC</td><td>Rest: RMSSD</td><td>DR: max/min</td><td>PI</td></tr><tr><td>Ancova F</td><td>10.854</td><td>8.492</td><td>9.016</td><td>0.380</td><td>6.512</td><td>0.493</td><td>6.467</td><td>2.70</td></tr><tr><td... |
7cd58f259919390bef4a9b742061d74f296e4937b2e3608de6822f9ffcb338b6.png | complex | <table><tr><td>Target<sup>a</sup></td><td>Nucleotide sequence (5′ to 3′)</td><td>Amplicon size (bp)</td><td>Reference</td></tr><tr><td rowspan="2"><i>cfb</i><sup>b</sup></td><td>F: CACACATGCTGTTGGAGTTCAGTTGA</td><td rowspan="2">138</td><td>This study</td></tr><tr><td>R: ACGAAGTCGACAGCATCACACGAAA</td><td></t... |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.